[Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology; D001921:Brain / Q000378:metabolism; D001971:Bromocriptine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008781:Methyltyrosines / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D011957:Receptors, Opioid / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D013570:Synaptic Membranes / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects
D000067956:Adenylyl Cyclase Inhibitors; D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D008781:Methyltyrosines; D011954:Receptors, Dopamine; D011957:Receptors, Opioid; D001971:Bromocriptine; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid
Problema neĭronal'noĭ retseptsii i dofaminovaia gipoteza shizofrenii.